Akso Health (AHG) Receivables - Other (2017 - 2023)

Akso Health has reported Receivables - Other for 6 years, with the latest figure at $26.2 million in Q1 2023.

• For the quarter ending Q1 2023, Receivables - Other rose 31.03% year-over-year to $26.2 million; the trailing twelve-month figure through Mar 2023 stood at $26.2 million (up 31.03% YoY), and the FY2023 full-year result was $1.5 million, down 92.36% from the prior year.
• Receivables - Other for Q1 2023 stood at $26.2 million, up from $20.0 million in the prior quarter.
• The five-year high for Receivables - Other was $26.2 million in Q1 2023, with the low at $29801.0 in Q1 2019.
• Historically, Receivables - Other has averaged $12.4 million across 5 years, with a median of $12.3 million in 2021.
• Annual changes were most pronounced in 2020 — Receivables - Other soared 79091.97% — and 2021, when it slumped 99.87%.
• Akso Health's Receivables - Other stood at $29801.0 in 2019, then soared by 79091.97% to $23.6 million in 2020, then slumped by 80.92% to $4.5 million in 2021, then jumped by 344.06% to $20.0 million in 2022, then surged by 31.03% to $26.2 million in 2023.
• The last three Receivables - Other figures came in at $26.2 million (Q1 2023), $20.0 million (Q1 2022), and $4.5 million (Q3 2021), per Business Quant data.